- ►geyseco.info [PDF] JJ Meier - Diabetologia, 2008 - Springer Abstract Beta cell deficiency underlies both type 1 and type 2 diabetes, and
restoration or replacement of beta cell function is therefore the logical
long-term solution to therapy. This review sets out to describe the defects ... Cited by 16 - Related articles - BL Direct - All 6 versions
T Hubert, G Strecker, V Gmyr, L Arnalsteen, … - American Journal of Transplantation, 2008 - ccmjournal.org D espite advances in diagnostic modalities and the improve- ment of clinical
care tech- niques, pyogenic liver ab- scess (PLA) is still a critical illness
with high morbidity and mortality rates. Its clinical incidence ranges from ... Cited by 7 - Related articles - BL Direct - All 5 versions
P Palsamy, S Subramanian - Biomedicine & Pharmacotherapy, 2008 - Elsevier Resveratrol is a polyphenolic phytoalexin produced in appreciable amounts as a
secondary metabolite in grapevines in response to fungal infections. Based on
the present knowledge, it appears to be a promising bioactive natural ... Cited by 6 - Related articles - All 2 versions
D Pipeleers, M Chintinne, B Denys, G … - Diabetes, Obesity and Metabolism, 2008 - interscience.wiley.com Type 1 and type 2 diabetes have often been presented as disease forms that
profoundly differ in the presence and pathogenic significance of a reduced
β-cell mass. We review evidence indicating that the β-cell mass in type 1 ... Cited by 2 - Related articles - All 2 versions
- ►diabetesjournals.org [PDF] SJ Kim, C Nian, DJ Doudet, CHS McIntosh - Diabetes, 2008 - Am Diabetes Assoc From the Department of Cellular & Physiological Sciencesand the Diabetes
Research Group, Life Sciences Institute 1 , University of British Columbia, 2350
Health Sciences Mall, the Department of Medicine 2 , Vancouver, BC, V6T ... Cited by 1 - Related articles - All 2 versions
PF Antkowiak, SA Tersey, JD Carter, MH … - American Journal of Physiology- Endocrinology And …, 2009 - Am Physiological Soc Loss of β-cell function in type 1 and type 2 diabetes leads to metabolic
dysregulation and inability to maintain normoglycemia. Noninvasive imaging of
β-cell function in vivo would therefore provide a valuable diagnostic and ... Cited by 1 - Related articles - All 3 versions
SJ Kim, C Nian, DJ Doudet, CHS McIntosh - Diabetes, 2008 - Am Diabetes Assoc OBJECTIVE—Dipeptidyl peptidase-IV (DPP-IV) inhibitors have been introduced as
therapeutics for type 2 diabetes. They partially act by blocking degradation of
the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent ... Cited by 3 - Related articles - BL Direct - All 5 versions
PA Halban - Diabetes, Obesity and Metabolism, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 1 - Related articles - All 2 versions
DKC Cooper, A Casu - Xenotransplantation, 2009 - interscience.wiley.com Abstract: Pre-clinical efficacy and complication data required to justify a
porcine islet transplantation clinical trial have been considered. To be
relevant to clinical islet transplantation, pre-clinical data should be ... Related articles - All 2 versions
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
